# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001171843-19-002642
Filing Date
2019-04-25
Accepted
2019-04-25 16:10:15
Documents
6
Effectiveness Date
2019-04-25

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | defa14a_042519.htm | DEFA14A | 12860
2 | GRAPHIC | logo.jpg | GRAPHIC | 33624
3 | GRAPHIC | card_01.jpg | GRAPHIC | 188034
4 | GRAPHIC | card_02.jpg | GRAPHIC | 302148
5 | GRAPHIC | card_03.jpg | GRAPHIC | 113512
6 | GRAPHIC | card_04.jpg | GRAPHIC | 63933
| Complete submission text file | 0001171843-19-002642.txt |  | 978494

Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

EIN.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-14027 | Film No.: 19767535
SIC: 3841 Surgical & Medical Instruments & Apparatus